Orca-T’s Display of Decreased NRM, Increased RFS May Contribute to Favorable OS in Hematologic Malignancies
OncLive,
Orca-T in Hematologic Malignancies | Image credit: © Свет Лана – stock.adobe.com A retrospective improvement in overall…
Orca-T in Hematologic Malignancies | Image credit: © Свет Лана – stock.adobe.com A retrospective improvement in overall…
Allo-HCT in Hematologic Malignancies | stock.adobe.com Treatment with Orca-T led to a low rate of graft-vs-host disease (GVHD)…